Page last updated: 2024-12-07

biotinyl-4-nitrophenyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Biotinyl-4-nitrophenyl ester is a synthetic compound used in various applications, including protein labeling, enzyme assays, and bioconjugation. It is synthesized by reacting biotin with 4-nitrophenol in the presence of a suitable coupling reagent, such as dicyclohexylcarbodiimide (DCC) or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). The nitrophenyl group serves as a leaving group, facilitating the attachment of biotin to various molecules, including proteins, peptides, and other biomolecules. The ester bond formed between biotin and the nitrophenol is susceptible to hydrolysis under basic conditions, allowing for controlled release of biotin or its conjugates. Biotinyl-4-nitrophenyl ester is studied extensively due to its utility in various research areas, including: 1. Protein labeling: Biotinylation of proteins using this reagent allows for easy detection and purification of target proteins using avidin- or streptavidin-based affinity chromatography. 2. Enzyme assays: This compound can be used to label enzymes with biotin, enabling the development of sensitive enzyme assays based on biotin-avidin interactions. 3. Bioconjugation: Biotinyl-4-nitrophenyl ester is a valuable tool for attaching biotin to various molecules, such as antibodies, nucleic acids, and polymers, for specific targeting and labeling purposes. 4. Drug delivery: Biotinylation of drug molecules using this reagent can facilitate targeted drug delivery to cells expressing biotin receptors, enhancing therapeutic efficacy and reducing side effects.'

Cross-References

ID SourceID
PubMed CID83848
SCHEMBL ID264799
MeSH IDM0043385

Synonyms (26)

Synonym
(+)-biotin 4-nitrophenyl ester, 98%
biotinyl-4-nitrophenyl ester
(4-nitrophenyl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate
biotin-p-nitrophenyl ester
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, 4-nitrophenyl ester, (3as-(3aalpha,4beta,6aalpha))-
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, 4-nitrophenyl ester, (3as,4s,6ar)-
33755-53-2
B4009
(+)-biotin 4-nitrophenyl ester
d-biotin p-nitrophenyl ester
AKOS015900654
SCHEMBL264799
J-500047
4-nitrophenyl 5-((3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanoate
(+)-biotin-onp
mfcd15141972
DTXSID80187424
biotin p-nitrophenyl ester
AS-11379
methyl 4-((2-amino-1-methyl-1h-benzo[d]imidazol-4-yl)oxy)-3,5-dimethoxybenzoate
C74732
HY-130888
CS-0116311
biotin-onp
BP-29711
AKOS040743774

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response relationships revealed that at concentrations as low as 1 micromolar, both biotin and its analog caused maximal augmentation of guanylate cyclase activity."( Biotin enhances guanylate cyclase activity.
Vesely, DL, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.46 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]